全文获取类型
收费全文 | 401227篇 |
免费 | 26986篇 |
国内免费 | 4799篇 |
专业分类
耳鼻咽喉 | 5342篇 |
儿科学 | 8432篇 |
妇产科学 | 10298篇 |
基础医学 | 55805篇 |
口腔科学 | 12122篇 |
临床医学 | 33201篇 |
内科学 | 81328篇 |
皮肤病学 | 8683篇 |
神经病学 | 28366篇 |
特种医学 | 14742篇 |
外国民族医学 | 100篇 |
外科学 | 63212篇 |
综合类 | 14108篇 |
现状与发展 | 5篇 |
一般理论 | 65篇 |
预防医学 | 18999篇 |
眼科学 | 10062篇 |
药学 | 33555篇 |
24篇 | |
中国医学 | 3535篇 |
肿瘤学 | 31028篇 |
出版年
2021年 | 3778篇 |
2020年 | 2573篇 |
2019年 | 3526篇 |
2018年 | 5333篇 |
2017年 | 4141篇 |
2016年 | 4260篇 |
2015年 | 5107篇 |
2014年 | 7041篇 |
2013年 | 8545篇 |
2012年 | 11643篇 |
2011年 | 12086篇 |
2010年 | 7393篇 |
2009年 | 6795篇 |
2008年 | 10694篇 |
2007年 | 11581篇 |
2006年 | 11430篇 |
2005年 | 10534篇 |
2004年 | 9555篇 |
2003年 | 9401篇 |
2002年 | 8855篇 |
2001年 | 28767篇 |
2000年 | 29349篇 |
1999年 | 24341篇 |
1998年 | 5590篇 |
1997年 | 4677篇 |
1996年 | 4146篇 |
1995年 | 3771篇 |
1994年 | 3399篇 |
1993年 | 3008篇 |
1992年 | 16223篇 |
1991年 | 14963篇 |
1990年 | 14282篇 |
1989年 | 14081篇 |
1988年 | 12675篇 |
1987年 | 12145篇 |
1986年 | 11156篇 |
1985年 | 10375篇 |
1984年 | 6930篇 |
1983年 | 5608篇 |
1982年 | 2723篇 |
1979年 | 5481篇 |
1978年 | 3345篇 |
1977年 | 2963篇 |
1975年 | 2636篇 |
1974年 | 3065篇 |
1973年 | 2863篇 |
1972年 | 2828篇 |
1971年 | 2773篇 |
1970年 | 2509篇 |
1969年 | 2543篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Yi Li Ying Chen Xiang Li Jian Wu Jing-Ying Pan Ri-Xin Cai Ri-Yun Yang Xiao-Dong Wang 《中国神经再生研究》2019,(9)
In the search for a therapeutic schedule for spinal cord injury, it is necessary to understand key genes and their corresponding regulatory networks involved in the spinal cord injury process. However, ad hoc selection and analysis of one or two genes cannot fully reveal the complex molecular biological mechanisms of spinal cord injury. The emergence of second-generation sequencing technology(RNA sequencing) has provided a better method. In this study, RNA sequencing technology was used to analyze differentially expressed genes at different time points after spinal cord injury in rat models established by contusion of the eighth thoracic segment. The numbers of genes that changed significantly were 944, 1362 and 1421 at 1, 4 and 7 days after spinal cord injury respectively. After gene ontology analysis and temporal expression analysis of the differentially expressed genes, C5ar1, Socs3 and CCL6 genes were then selected and identified by real-time polymerase chain reaction and western blot assay. The mRNA expression trends of C5ar1, Socs3 and CCL6 genes were consistent with the RNA sequencing results. Further verification and analysis of C5ar1 indicate that the level of protein expression of C5ar1 was consistent with its nucleic acid level after spinal cord injury. C5ar1 was mainly expressed in neurons and astrocytes. Finally, the gene Itgb2,which may be related to C5ar1, was found by Chilibot database and literature search. Immunofluorescence histochemical results showed that the expression of Itgb2 was highly consistent with that of C5ar1. Itgb2 was expressed in astrocytes. RNA sequencing technology can screen differentially expressed genes at different time points after spinal cord injury. Through analysis and verification, genes strongly associated with spinal cord injury can be screened. This can provide experimental data for further determining the molecular mechanism of spinal cord injury, and also provide possible targets for the treatment of spinal cord injury. This study was approved ethically by the Laboratory Animal Ethics Committee of Jiangsu Province, China(approval No. 2018-0306-001) on March 6, 2018. 相似文献
42.
43.
Y. Ermias I.A. Morgan K.M. Curtis M.K. Whiteman L.G. Horton L.B. Zapata 《Contraception》2019,99(5):300-305
ObjectiveIdentify factors associated with healthcare providers' frequency of depot medroxyprogesterone acetate (DMPA) provision to adolescents.Study designWe analyzed data from surveys mailed to a nationally representative sample of public-sector providers and office-based physicians (n=1984). We estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of factors associated with frequent DMPA provision to adolescents in the past year.ResultsAlthough most providers (>95%) considered DMPA safe for adolescents, fewer reported frequent provision (89% of public-sector providers; 64% of office-based physicians). Among public-sector providers, factors associated with lower odds of frequent provision included working in settings without Title X funding (aOR 0.44, 95% CI 0.30–0.64), reporting primary care as their primary clinical focus versus reproductive or adolescent health (aOR 0.42, 95% CI 0.28–0.61), and providing fewer patients with family planning services. Among office-based physicians, factors associated with lower odds of frequent provision included specializing in obstetrics/gynecology (aOR 0.50, 95% CI 0.27–0.91) and family medicine (aOR 0.21, 95% CI 0.09–0.47) versus adolescent medicine, completing training ≥15 versus <5 years ago (aOR 0.27, 95% CI 0.09–0.83), and reporting that 0–24% of patients pay with Medicaid or other government healthcare assistance versus ≥50% (aOR 0.23, 95% CI 0.09–0.61). The reason most commonly reported by providers for infrequent DMPA provision was patient preference for another method.ConclusionsWhile most providers reported frequently providing DMPA to adolescents, training on evidence-based recommendations for contraception, focused on subgroups of providers with lower odds of frequent DMPA provision, may increase adolescents' access to contraception.ImplicationsAlthough >95% of providers considered depot medroxyprogesterone (DMPA) a safe contraceptive for adolescents, only 89% of public-sector providers and 64% of office-based physicians reported frequently providing DMPA to adolescents. Provider training on evidence-based recommendations for contraception counseling and provision may increase adolescents' access to DMPA and all methods of contraception. 相似文献
44.
Prevention Science - This study aimed to evaluate the effectiveness of the drug and violence resistance educational program (PROERD) on short-term secondary outcomes, such as intentions to use... 相似文献
45.
46.
本研究拟探讨染料木黄酮对前列腺癌细胞LNCaP和CWR22RV1的增殖、迁移和侵袭能力的影响。一、材料与方法1.材料:前列腺癌细胞株LNCaP和CWR22RV1(中国科学院上海生命科学研究院);Genistein(天津科瑞泰科技有限公司);RPMI 1640、胎牛血清(FBS)、胰蛋白酶(美国Gibco公司);E-钙黏蛋白(E-cadherin)、N-钙黏蛋白(N-cadherin)、波形蛋白(Vimentin,Abcam公司);聚氰基丙烯酸正丁酯(BCA)试剂盒、十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)上样缓冲液(×5)及蛋白质印迹法(Western blot)试剂盒(上海市碧云天生物公司);2.实验方法:采用噻唑蓝(MTT)实验、划痕实验和Transwell实验检测Genistein对细胞增殖、迁移及侵袭能力的影响。采用Western blot检测E-cadherin、N-cadherin、Vimentin、CD44和Oct-4的表达水平。 相似文献
47.
48.
49.
目的 分析2007-2017年浙江省24 388例罕见病住院病例特征,为制定罕见病防控策略提供依据。方法 收集2007-2017年浙江省10家三级甲等(三甲)医院罕见病住院病例资料和各年度住院数,进行描述性统计分析。结果 罕见病病例共24 388例,占住院总例数的2.69‰(24 388/9 054 201),病例数居前3位的疾病类型依次为"血液和造血器官疾病以及某些涉及免疫机能的异常"(占32.81%,8 001/24 388)、"先天性畸形、变形和染色体异常"(占24.87%,6 065/24 388)和"神经系统疾病"(占19.01%,4 635/24 388);2007-2017年罕见病病例数呈逐年增长趋势,年均增幅19.69%,而罕见病例数占同期住院总例数比例仅在2016-2017年明显上升,各类型罕见病时间分布呈不同特征;罕见病的病例数男女性别比为1.35:1(13 990/10 398),男女性别比最高的3类疾病依次为"消化系统疾病"(4.45:1,1 180/265)、"损伤、中毒和外因的某些其他后果"(3.51:1,281/80)和"神经系统疾病"(2.26:1,3 213/1 422);各年龄段罕见病类型、各类型罕见病年龄分布均呈不同特征;病例数居前10位的疾病占全部罕见病例数的53.55%(13 060/24 388),其中前3位疾病分别为成人粒细胞缺乏症(14.41%,3 515/24 388)、皮质基底核退化症(7.60%,1 854/24 388)和亨诺克-舍恩莱因紫癜(6.01%,1 466/24 388)。结论 本研究分析的浙江省2007-2017年24 388例罕见病住院病例的特征资料,是推动我国罕见病的研究、监测或登记数据库构建、制定防控策略的参考依据。 相似文献
50.